Optimum Investment Advisors Invests $43,000 in Doximity, Inc. (NASDAQ:DOCS)

Optimum Investment Advisors acquired a new position in Doximity, Inc. (NASDAQ:DOCS) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 800 shares of the company’s stock, valued at approximately $43,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Shaker Investments LLC OH acquired a new position in Doximity in the fourth quarter worth $559,000. Penserra Capital Management LLC acquired a new position in Doximity in the third quarter worth $2,384,000. Principal Financial Group Inc. boosted its holdings in Doximity by 1.5% in the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company’s stock worth $15,695,000 after purchasing an additional 4,282 shares during the period. Newbridge Financial Services Group Inc. acquired a new position in Doximity in the fourth quarter worth $362,000. Finally, Stratos Wealth Partners LTD. acquired a new position in Doximity in the fourth quarter worth $203,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Trading Up 0.4 %

Shares of Doximity stock opened at $63.01 on Monday. The company’s 50-day moving average price is $64.42 and its two-hundred day moving average price is $53.63. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21. The stock has a market cap of $11.76 billion, a PE ratio of 63.01, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34.

Analysts Set New Price Targets

A number of equities analysts have commented on DOCS shares. Raymond James reaffirmed an “outperform” rating and issued a $83.00 price objective (up previously from $65.00) on shares of Doximity in a report on Friday, February 7th. Bank of America boosted their price target on shares of Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a report on Monday, January 6th. The Goldman Sachs Group boosted their price target on shares of Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a report on Monday, February 10th. KeyCorp reduced their price target on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a report on Wednesday, January 8th. Finally, Wells Fargo & Company reissued an “equal weight” rating on shares of Doximity in a report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $64.22.

Insiders Place Their Bets

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 37.40% of the stock is owned by company insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.